Jill C. Milne - Net Worth and Insider Trading
Jill C. Milne Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jill C. Milne owns 1 companies in total, including Astria Therapeutics Inc (ATXS) .
Click here to see the complete history of Jill C. Milne’s form 4 insider trades.
Insider Ownership Summary of Jill C. Milne
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ATXS | Astria Therapeutics Inc | 2015-06-24 | director & President and CEO |
Jill C. Milne Trading Performance
Jill C. Milne Ownership Network
Jill C. Milne Owned Company Details
What does Astria Therapeutics Inc do?
Who are the key executives at Astria Therapeutics Inc?
Jill C. Milne is the director & President and CEO of Astria Therapeutics Inc. Other key executives at Astria Therapeutics Inc include Chief Medical Officer Christopher Morabito , director & 10 percent owner Perceptive Life Sciences Master Fund Ltd , and Chief Business Officer Andrea Matthews .
Astria Therapeutics Inc (ATXS) Insider Trades Summary
Over the past 18 months, Jill C. Milne made no insider transaction in Astria Therapeutics Inc (ATXS). Other recent insider transactions involving Astria Therapeutics Inc (ATXS) include a net purchase of 4,295,958 shares made by Perceptive Life Sciences Master Fund Ltd , and a net sale of 20,000 shares made by Christopher Morabito .
In summary, during the past 3 months, insiders sold 0 shares of Astria Therapeutics Inc (ATXS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 20,000 shares of Astria Therapeutics Inc (ATXS) were sold and 4,295,958 shares were bought by its insiders, resulting in a net purchase of 4,275,958 shares.
Astria Therapeutics Inc (ATXS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Astria Therapeutics Inc Insider Transactions
Jill C. Milne Mailing Address
Above is the net worth, insider trading, and ownership report for Jill C. Milne. You might contact Jill C. Milne via mailing address: C/o Catabasis Pharmaceuticals, Inc., One Kendall Sq., Bldg. 1400e, Ste.b14202, Cambridge Ma 02139.